Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
50°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adma Biologics
(NQ:
ADMA
)
19.77
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
100
Open
19.77
Bid (Size)
19.48 (1)
Ask (Size)
19.76 (1)
Prev. Close
19.77
Today's Range
19.77 - 19.77
52wk Range
3.060 - 20.37
Shares Outstanding
196,357,149
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Looking for growth without the hefty price tag? Consider NASDAQ:ADMA.
September 24, 2024
Looking for growth without the hefty price tag? Consider NASDAQ:ADMA.
Via
Chartmill
In-Depth Examination Of 4 Analyst Recommendations For ADMA Biologics
September 20, 2024
Via
Benzinga
Performance
YTD
+334.51%
+334.51%
1 Month
+19.31%
+19.31%
3 Month
+73.42%
+73.42%
6 Month
+206.99%
+206.99%
1 Year
+460.06%
+460.06%
More News
Read More
ADMA Biologics Set to Join S&P SmallCap 600 Index
September 17, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
September 10, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Assessing ADMA Biologics: Insights From 4 Financial Analysts
August 12, 2024
Via
Benzinga
What's Going On With ADMA Biologics Stock Monday?
September 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
September 09, 2024
Via
Benzinga
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark
September 05, 2024
Via
Investor's Business Daily
'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics
August 30, 2024
Via
Benzinga
Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers
August 29, 2024
Via
Investor's Business Daily
Biohaven Stock Earns Relative Strength Rating Upgrade
August 21, 2024
Via
Investor's Business Daily
SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
August 21, 2024
Via
Investor's Business Daily
Immunome Stock Sees RS Rating Jump To 91
August 20, 2024
Via
Investor's Business Daily
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
August 19, 2024
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
August 19, 2024
Via
Benzinga
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
August 14, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
Via
Benzinga
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
August 09, 2024
Via
Benzinga
ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82
August 06, 2024
Via
Investor's Business Daily
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
August 01, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Vir Biotechnology Stock Reaches 80-Plus RS Rating Benchmark
July 26, 2024
Via
Investor's Business Daily
Beam Therapeutics Stock Earns RS Rating Jump To 85
July 24, 2024
Via
Investor's Business Daily
Jim Cramer Recommends Not Selling Vertiv, Says Buy This Social Media Stock 'Hand Over Fist'
July 23, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.